Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Total number of shares and voting rights in Zealand at August 31, 2017

Zealand Pharma
Posted on: 31 Aug 17

Company announcement - No. 42 / 2017

Total number of shares and voting rights in Zealand at August 31, 2017

Copenhagen, August 31, 2017 - In accordance with Section 10 of the Danish Statutory Order on Issuers' Disclosure Obligations, Zealand issues announcements regarding the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. 

In Company announcement Nos. 35 / 2017 of August 14, 2017 and 38 / 2017 of August 18, 2017, Zealand announced an increase in its share capital related to the initial public offering of American Depositary Shares in the United States (please refer to Company announcements Nos. 29 / 2017 to 38 / 2017 dated from August 1, 2017 until August 18, 2017). Following these announcements, the table below lists the total number of shares and voting rights in Zealand at August 31, 2017:

 

Date
Number of shares
(nominal value of DKK 1 each)
Share capital
(nominal value in DKK)
Number of voting rights
August 31, 201730,718,65230,718,65230,718,652

For further information, please contact:

Mats Blom, Executive Vice President and Chief Financial Officer
Tel.: +45 31 53 79 73, e-mail: mabl@zealandpharma.com

A bout Zealand Pharma A/S
Zealand (Nasdaq Copenhagen and New York: ZEAL) is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines.
Zealand is based in Copenhagen (Glostrup), Denmark.

42 -17_0831 Number of shares and voting rights in Zealand at August 31


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Zealand Pharma via GlobeNewswire
HUG#2130501
GlobeNewswire
globenewswire.com

Last updated on: 01/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.